300 related articles for article (PubMed ID: 24838121)
1. [Controversy over the use of hydroxyethyl starch solutions. Is the use of low molecular weight hydroxyethyl starch contraindicated?].
Sánchez CA; Asuero MS;
Rev Esp Anestesiol Reanim; 2014; 61(6):299-303. PubMed ID: 24838121
[No Abstract] [Full Text] [Related]
2. Renal dysfunction after hydroxyethyl starch.
Celik I
Anesth Analg; 2004 Jul; 99(1):309-310. PubMed ID: 15281561
[No Abstract] [Full Text] [Related]
3. [Volume replacement with hydroxyethyl starch: is there an influence on kidney function?].
Suttner S; Boldt J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):71-7. PubMed ID: 14767795
[TBL] [Abstract][Full Text] [Related]
4. EMA confirms that hydroxyethyl starch solutions should not be used in critically ill, sepsis, or burns patients.
Mayor S
BMJ; 2013 Oct; 347():f6197. PubMed ID: 24126958
[No Abstract] [Full Text] [Related]
5. Deleterious renal effects of hydroxyethyl starch 130/0.4 and 200/0.5 solutions.
Davidson IJ
Eur J Anaesthesiol; 2007 Oct; 24(10):892-3. PubMed ID: 17977101
[No Abstract] [Full Text] [Related]
6. Crystalloid versus colloid versus colloid: all colloids are not created equal.
Traylor RJ; Pearl RG
Anesth Analg; 1996 Aug; 83(2):209-12. PubMed ID: 8694293
[No Abstract] [Full Text] [Related]
7. Hydroxyethyl starch and granulocyte transfusions: considerations of utility and toxicity profile for patients and donors.
Ambruso DR
Transfusion; 2015 Apr; 55(4):911-8. PubMed ID: 25315227
[TBL] [Abstract][Full Text] [Related]
8. Starch solutions in Australia: the empire strikes back.
Bellomo R
Crit Care Resusc; 2013 Dec; 15(4):253-4. PubMed ID: 24289503
[No Abstract] [Full Text] [Related]
9. [Volume replacement with artifical colloids].
Nitsch E
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):255-60. PubMed ID: 9617426
[No Abstract] [Full Text] [Related]
10. Hydroxyethyl starch.
Treib J; Haass A
J Neurosurg; 1997 Mar; 86(3):574-5. PubMed ID: 9046322
[No Abstract] [Full Text] [Related]
11. Renal impact of fluid management with colloids.
Boldt J
Eur J Anaesthesiol; 2007 Oct; 24(10):891-2. PubMed ID: 17977100
[No Abstract] [Full Text] [Related]
12. Volume therapy with hydroxyethyl starches: are we throwing the anesthesia baby out with the intensive care unit bathwater?
Irwin MG; Gan TJ
Anesth Analg; 2014 Sep; 119(3):737-739. PubMed ID: 25137005
[No Abstract] [Full Text] [Related]
13. Risks of hydroxyethyl starch 130/0.4 in cardiac surgery.
Haynes GR
J Pharm Pract; 2014 Feb; 27(1):17-8. PubMed ID: 24436438
[No Abstract] [Full Text] [Related]
14. Acute kidney injury in cardiac surgery patients receiving hydroxyethyl starch solutions.
Bayer O; Reinhart K
Crit Care; 2015 May; 19(1):209. PubMed ID: 25940561
[No Abstract] [Full Text] [Related]
15. Is the literature inconclusive about the harm from HES? Yes.
Ertmer C; Annane D; Van Der Linden P
Intensive Care Med; 2017 Oct; 43(10):1520-1522. PubMed ID: 27007102
[No Abstract] [Full Text] [Related]
16. Hydroxyethyl starch 130/0.4 and postoperative acute kidney injury.
Groeneveld AB; Navickis RJ; Wilkes MM
Anesthesiology; 2013 Sep; 119(3):733-5. PubMed ID: 23962942
[No Abstract] [Full Text] [Related]
17. Intravascular volume therapy with colloids in cardiac surgery.
Lange M; Ertmer C; Van Aken H; Westphal M
J Cardiothorac Vasc Anesth; 2011 Oct; 25(5):847-55. PubMed ID: 20709570
[No Abstract] [Full Text] [Related]
18. An international review of HES.
Riou B; Cittanova ML
Intensive Care Med; 1999 Nov; 25(11):1340-1. PubMed ID: 10654230
[No Abstract] [Full Text] [Related]
19. Renal impairment in cardiac surgery patients receiving hydroxyethyl starch.
Wiedermann CJ
Intensive Care Med; 2004 Mar; 30(3):519-20; author reply 521. PubMed ID: 14727021
[No Abstract] [Full Text] [Related]
20. Hydroxyethyl starch 130/0.4: safe for the kidney in surgical patients?
Wiedermann CJ
Anesthesiology; 2013 Sep; 119(3):735-6. PubMed ID: 23962943
[No Abstract] [Full Text] [Related]
[Next] [New Search]
